18 th International Webinar on

 Pharmacovigilance & Drug Safety

Scientific Program

Dr. Carolle-Laure

Dr. Carolle-Laure

Dr. Carolle-Laure KPOUMIE MD , phd in public health and social medecine, France

Title: RARE DISEASES AND HANDICAP: State : medical, social, health policy in developing countries. Case of Cameroon: about a case: Cushing's disease

Biography:

Dr. Carolle-Laure KPOUMIE MD , phd in public health and social medecine, has worked as pediatric assistant physician in pediatric’s department of faculty of medicine in Cameroon, as clinical researcher, scientific writing, public health, oncology, rares diseases,orphan drugs, handicap, internal medicine and continued her career in France. She participates in many congress with studies made in hospitals on relevant cases in the framework Studies and clinical research. She became head of department, director, where she continued her research, writing of treatment protocols in different departments for common pathologies encountered in her context, managing Epidemic crisis , rares diseases, participates in studies on neonatal mortality in underdeveloped countries. She work on ADR in hospital following drug administration, pharmacovigilance, vaccinovigilance, biovigilance, materiovigilance, pharmacovigilance in underdeveloped countries, articles, medical information and therapeutic safety, clinical trials, Post-marketing, and other’s studies.

Abstract

Rare and orphan diseases are a reality throughout the world and a real public health problem in developing countries. The great precariousness in which the populations live increases their impact and their gravity by the absence of information, technical platform, means of detection, actual presence of research and clinical studies on these territories, lack of awareness of the detection, diagnosis, without forgetting that the means of care and prevention are sometimes inexistent or little known and especially expensive in countries where the populations are poor, without mutual or social security as in industrialized countries .
This work will focus on a patient case presenting a rare disease in this case Cushing's disease. A case that occurred in Cameroon in order to establish in a practical way this major and yet ignored, neglected issue in a health system with poor specialized structures, technical platforms, and without the support of the pharmaceutical laboratories that could with the health system of these poor countries set up a system of refueling in the sense of the social view the cost that requires the monitoring of these long pathologies that make autonomous living almost impossible, also life-threatening.
In Cameroon, there have been difficulties in the care and monitoring of this young patient since childhood through the phase of the pubertal transition, adolescence, to adulthood.
  It is therefore important to organize the follow-up of these patients, by developing specific programs of medical follow-up, psychological care, and social integration programs. Health policies should invest in better support.
 

  • Pharmacovigilance Significance & Scope
  • Clinical Pharmacy and its Role in Treatment
  • Biosimilars Pharmacovigilance and Risk Management
  • Clinical Drug Toxicity
  • Biomakers
  • Pharmacovigilance for Herbal Medicines
  • Pharmacoepidemiology
  • Serotonin Pharmacology
  • Pharmacogenetics and Pharmacogenomics
  • Nano Pharmaceuticals